We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$19.6B
AUM Growth
-$1.62B
Cap. Flow
-$2.45B
Cap. Flow %
-12.52%
Top 10 Hldgs %
28.04%
Holding
2,127
New
700
Increased
505
Reduced
388
Closed
303

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$316M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$222M
3
AMZN icon
Amazon
AMZN
+$152M
4
INSM icon
Insmed
INSM
+$149M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$126M

Top Sells

Rank Stock Value
1
VGT icon
Vanguard Information Technology ETF
VGT
+$1.68B
2
WRB icon
W.R. Berkley
WRB
+$683M
3
LLY icon
Eli Lilly
LLY
+$229M
4
COST icon
Costco
COST
+$188M
5
PEP icon
PepsiCo
PEP
+$136M

Sector Composition

Rank Sector Weight
1 Healthcare 10.49%
2 Technology 8.24%
3 Financials 7%
4 Industrials 4.24%
5 Consumer Discretionary 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBU icon
1626
Caribou Biosciences
CRBU
$164M
$71.3K ﹤0.01%
44,840
-2,360
-5% -$4.95K
CAMP icon
1627
CAMP4 Therapeutics
CAMP
$266M
$69.6K ﹤0.01%
+11,361
New +$48.3K
GALT icon
1628
Galectin Therapeutics
GALT
$348M
$68.4K ﹤0.01%
16,435
-865
-5% -$4.55K
ASST icon
1629
CALL
Strive Inc
ASST
$1.05B
$68.3K ﹤0.01%
4,625
+820
+22% +$19.6K
BLNK icon
1630
Blink Charging
BLNK
$87.9M
$67.5K ﹤0.01%
101,219
+1,219
+1% +$1.76K
CCCC icon
1631
C4 Therapeutics
CCCC
$412M
$67.5K ﹤0.01%
35,340
-2,860
-7% -$6.78K
ASST icon
1632
Strive Inc
ASST
$1.05B
$66.4K ﹤0.01%
4,500
+4,070
+947% +$97.2K
VOYG
1633
Voyager Technologies
VOYG
$2.54B
$62.7K ﹤0.01%
+2,400
New +$65.1K
EXAS
1634
CALL
DELISTED
Exact Sciences
EXAS
$60.9K ﹤0.01%
+600
New +$48.2K
NU icon
1635
Nu Holdings
NU
$66.9B
$60.1K ﹤0.01%
3,591
-217,793
-98% -$3.5M
HTGC icon
1636
Hercules Capital
HTGC
$3.23B
$56K ﹤0.01%
2,977
+1,585
+114% +$28.6K
MRVI icon
1637
Maravai LifeSciences
MRVI
$919M
$55.3K ﹤0.01%
17,000
– –
BTG icon
1638
B2Gold
BTG
$6.64B
$54.7K ﹤0.01%
+12,135
New +$56.6K
BDTX icon
1639
Black Diamond Therapeutics
BDTX
$112M
$52.6K ﹤0.01%
21,660
-1,140
-5% -$4.04K
RIVN icon
1640
Rivian
RIVN
$23.2B
$52.6K ﹤0.01%
+2,670
New +$42.4K
PRCH icon
1641
Porch Group
PRCH
$1.8B
$51.5K ﹤0.01%
+5,640
New +$67.9K
GNLX icon
1642
Genelux
GNLX
$119M
$47.7K ﹤0.01%
+10,940
New +$59.1K
INDI icon
1643
indie Semiconductor
INDI
$854M
$47.3K ﹤0.01%
13,396
– –
CSGP icon
1644
PUT
CoStar Group
CSGP
$12.3B
$47.1K ﹤0.01%
+700
New +$49.6K
FLNC icon
1645
Fluence Energy
FLNC
$2.44B
$45.7K ﹤0.01%
+2,312
New +$43.6K
GDC icon
1646
GD Culture Group
GDC
$7.16M
$44.4K ﹤0.01%
+42
New +$47.5K
ZBRA icon
1647
Zebra Technologies
ZBRA
$17.8B
$44K ﹤0.01%
+181
New +$48.4K
TNYA icon
1648
Tenaya Therapeutics
TNYA
$163M
$41.4K ﹤0.01%
58,235
-3,065
-5% -$4.17K
GME.WS
1649
GameStop Corp Warrants
GME.WS
$40.7K ﹤0.01%
+13,518
New +$41.9K
RANI icon
1650
Rani Therapeutics
RANI
$89M
$40.3K ﹤0.01%
+29,870
New +$45.1K
64 65
66
67 68

Similar funds

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return

Jefferies Financial Group's Q4 2025 Portfolio in Review

As of Q4 2025, Jefferies Financial Group held 2,127 positions worth $19.6B, down 7.6% from $21.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jefferies Financial Group withdrew a net $2.45B in Q4 2025, closing 303 positions and reducing 388 holdings. Its most notable exit was Vanguard Information Technology ETF, an estimated $1.68B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Jefferies Financial Group opened a new position in Roivant Sciences worth $76.3M.

  • Jefferies Financial Group's largest Q4 2025 buy was Roivant Sciences: 3,514,833 shares worth $76.3M.
  • Jefferies Financial Group added most to NVIDIA in Q4 2025, an estimated $316M increase.
  • Jefferies Financial Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $229M.
  • Jefferies Financial Group fully exited Vanguard Information Technology ETF in Q4 2025, selling an estimated $1.68B.
  • Jefferies Financial Group's ten largest holdings make up 28% of its $19.6B portfolio in Q4 2025.
  • Jefferies Financial Group opened 700 new positions and closed 303 in Q4 2025.
  • Jefferies Financial Group's portfolio value fell 7.6% quarter-over-quarter to $19.6B.

Based on Jefferies Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.